LD-ER LBD001V

LD-ER LBD001V is a generic version of Faslodex with a  unique formulation technique.  LD-ER LBD001V is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

© All Rights Reserved by Lipont Pharmaceuticals 2014
linkedin icon
facebook icon
Webmail
logo-solo